Hindustan Bio Sciences Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 395126, "name": "Hind.Bio Science", "stock_name": "Hind.Bio Science", "full_name": "Hindustan Bio Sciences Ltd", "name_url": "stocks-analysis/hindbio-science", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "9.24", "chg": 0.44, "chgp": "5.0%", "dir": 1, "prev_price": "8.80", "mcapval": "9.00 Cr", "mcap": "Micro Cap", "scripcode": 532041, "symbol": "", "ind_name": "Software Products", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE597C01021", "curr_date": "Apr 17", "curr_time": "", "bse_nse_vol": "13.79 k", "exc_status": "Active", "traded_date": "Apr 17, 2026", "traded_date_str": "2026 04 17", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/hindbio-science-395126-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Hindustan Bio Sciences Gains 5.18%: 2 Key Factors Driving the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/hindustan-bio-sciences-gains-518-2-key-factors-driving-the-week-3943157", "imagepath": "", "date": "2026-04-11 17:10:56", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>6 Apr:</strong> Week opens at Rs.8.50</p>\n <p><strong>7 Apr:</strong> Golden Cross formation signals potential bullish breakout</p>\n <p><strong>8 Apr:</strong> Mojo Score upgraded to Sell from Strong Sell</p>\n <p><strong>10 Apr:</strong> Week closes at Rs.8.94 (+5.18%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.8.50</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.8.94</div><div class=\"stat-change positive\">+5.18%</div></..." }, { "title": "Hindustan Bio Sciences Ltd Upgraded to Sell Amid Mixed Technical and Fundamental Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/hindustan-bio-sciences-ltd-upgraded-to-sell-amid-mixed-technical-and-fundamental-signals-3936559", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/HindustanBioSci_mojoScore_3936559.png", "date": "2026-04-08 08:10:15", "description": "Hindustan Bio Sciences Ltd, a micro-cap player in the Software Products sector, has seen its investment rating upgraded from Strong Sell to Sell as of 7 April 2026. This change is primarily driven by a shift in technical indicators signalling a mildly bullish trend, despite persistent weaknesses in the company’s financial fundamentals and valuation metrics." }, { "title": "Golden Cross Forms in Hindustan Bio Sciences Ltd — On a Day the Stock Fell 4.9%. What the Mixed Signals Mean", "link": "https://www.marketsmojo.com/news/stocks-in-action/hindustan-bio-sciences-ltd-forms-golden-cross-indicating-potential-bullish-breakout-3936132", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/HindustanBioSci_goldencross_3936132.png", "date": "2026-04-07 18:00:12", "description": "The 50-day moving average has crossed above the 200-day moving average for Hindustan Bio Sciences Ltd, signalling a golden cross on 7 Apr 2026. Yet, the stock declined 4.94% on the same day, while monthly momentum indicators remain bearish. This divergence between the moving averages and price action calls for a detailed examination of the signal's reliability." }, { "title": "Hindustan Bio Sciences Ltd Gains 21.01%: Valuation and Quality Concerns Shape the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/hindustan-bio-sciences-ltd-gains-2101-valuation-and-quality-concerns-shape-the-week-3826722", "imagepath": "", "date": "2026-02-07 17:18:29", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>2 Feb:</strong> Quality grade downgraded to Below Average, Strong Sell rating assigned</p>\n <p><strong>2 Feb:</strong> Valuation metrics escalated, stock classified as very expensive</p>\n <p><strong>2 Feb:</strong> Stock price surged 10.06% despite Sensex decline</p>\n <p><strong>3-6 Feb:</strong> Mixed daily price movements with overall weekly gain of 21.01%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.7.44</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close..." }, { "title": "Hindustan Bio Sciences Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Expensive Valuation", "link": "https://www.marketsmojo.com/news/stock-recommendation/hindustan-bio-sciences-ltd-downgraded-to-strong-sell-amid-weak-fundamentals-and-expensive-valuation-3815717", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/HindustanBioSci_mojoScore_3815717.png", "date": "2026-02-02 08:19:59", "description": "Hindustan Bio Sciences Ltd has been assigned a Strong Sell rating with a Mojo Score of 21.0, reflecting significant concerns across quality, valuation, financial trends, and technical indicators. The downgrade from a previously ungraded status follows a comprehensive reassessment revealing deteriorating fundamentals, expensive market valuation, and mixed technical signals despite recent price gains." }, { "title": "Hindustan Bio Sciences Ltd Valuation Shifts Signal Elevated Price Risk", "link": "https://www.marketsmojo.com/news/stocks-in-action/hindustan-bio-sciences-ltd-valuation-shifts-signal-elevated-price-risk-3815281", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/HindustanBioSci_valuationdot_3815281.png", "date": "2026-02-02 08:01:09", "description": "Hindustan Bio Sciences Ltd, a player in the Software Products sector, has seen a marked shift in its valuation parameters, moving from a risky to a very expensive rating. Despite a strong short-term price rally, the company’s elevated price-to-earnings and price-to-book ratios raise questions about its price attractiveness relative to historical averages and peer benchmarks." }, { "title": "Hindustan Bio Sciences Ltd Quality Grade Downgrade Highlights Fundamental Challenges", "link": "https://www.marketsmojo.com/news/stocks-in-action/hindustan-bio-sciences-ltd-quality-grade-downgrade-highlights-fundamental-challenges-3815215", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/HindustanBioSci_qualitydot_3815215.png", "date": "2026-02-02 08:00:16", "description": "Hindustan Bio Sciences Ltd has seen its quality grade downgraded from \"Does Not Qualify\" to \"Below Average\" as of 1 February 2026, reflecting deteriorations in key business fundamentals. Despite a recent surge in share price, the company’s financial metrics reveal challenges in profitability, capital efficiency, and growth consistency, raising concerns for investors in the Software Products sector." }, { "title": "Hindustan Bio Sciences Q3 FY26: Profitability Returns But Volatility Remains High", "link": "https://www.marketsmojo.com/news/result-analysis/hindustan-bio-sciences-q3-fy26-profitability-returns-but-volatility-remains-high-3815022", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/HindustanBioSci_quaterlyResult_3815022.png", "date": "2026-01-31 21:01:08", "description": "Hindustan Bio Sciences Ltd., a micro-cap pharmaceutical company with a market capitalisation of just ₹7.00 crores, posted a net profit of ₹0.08 crores in Q3 FY26 (October-December 2025), marking a sharp recovery from the ₹0.06 crore loss reported in the previous quarter. The stock surged 4.88% to ₹7.09 on February 1, 2026, though it remains 31.30% below its 52-week high of ₹10.32 amid persistent concerns about operational stability and financial sustainability." }, { "title": "When is the next results date for Hindustan Bio Sciences Ltd?", "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-hindustan-bio-sciences-ltd-3797091", "imagepath": "", "date": "2026-01-20 23:16:12", "description": "The next results date for Hindustan Bio Sciences Ltd is scheduled for January 31, 2026...." } ], "total": 102, "sid": "395126", "stock_news_url": "https://www.marketsmojo.com/news/hindustan-bio-sciences-395126" }, "announcements": [ { "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018", "datetime": "14-Apr-2026", "details": "We are hereby submitting the certificate issued by Venture Capital and Corporate Investments Private Limited in compliance with the Regulation 74(5) of SEBI(Depositories and Participants) Regulation 2018 for the Fourth quarter and year ended on 31st March 2026", "source": "BSE" }, { "caption": "Closure of Trading Window", "datetime": "25-Mar-2026", "details": "The Trading window for the dealing in securities of the Company will remain closed from April 01 2026 till 48 hours after the announcement of Standalone Audited Financial results for the year ending on March 31 2026", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "02-Feb-2026", "details": "We are hereby submitting the Newspaper Advertisement in Hitech Edition (English Language) and Prajapalana (Telugu Language) regarding Unaudited Standalone financial results for the Third Quarter ended on December 31 2025", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

2 Feb: Quality grade downgraded to Below Average, Strong Sell rating assigned

2 Feb: Valuation metrics escalated, stock classified as very expensive

2 Feb: Stock price surged 10.06% despite Sensex decline

3-6 Feb: Mixed daily price movements with overall weekly gain of 21.01%

Week Open

Rs.7.44

Week Close...

Read full news article

Hindustan Bio Sciences Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Expensive Valuation

2026-02-02 08:19:59

Hindustan Bio Sciences Ltd has been assigned a Strong Sell rating with a Mojo Score of 21.0, reflecting significant concerns across quality, valuation, financial trends, and technical indicators. The downgrade from a previously ungraded status follows a comprehensive reassessment revealing deteriorating fundamentals, expensive market valuation, and mixed technical signals despite recent price gains.

Read full news article

Hindustan Bio Sciences Ltd Valuation Shifts Signal Elevated Price Risk

2026-02-02 08:01:09

Hindustan Bio Sciences Ltd, a player in the Software Products sector, has seen a marked shift in its valuation parameters, moving from a risky to a very expensive rating. Despite a strong short-term price rally, the company’s elevated price-to-earnings and price-to-book ratios raise questions about its price attractiveness relative to historical averages and peer benchmarks.

Read full news article

Hindustan Bio Sciences Ltd Quality Grade Downgrade Highlights Fundamental Challenges

2026-02-02 08:00:16

Hindustan Bio Sciences Ltd has seen its quality grade downgraded from "Does Not Qualify" to "Below Average" as of 1 February 2026, reflecting deteriorations in key business fundamentals. Despite a recent surge in share price, the company’s financial metrics reveal challenges in profitability, capital efficiency, and growth consistency, raising concerns for investors in the Software Products sector.

Read full news article

Hindustan Bio Sciences Q3 FY26: Profitability Returns But Volatility Remains High

2026-01-31 21:01:08

Hindustan Bio Sciences Ltd., a micro-cap pharmaceutical company with a market capitalisation of just ₹7.00 crores, posted a net profit of ₹0.08 crores in Q3 FY26 (October-December 2025), marking a sharp recovery from the ₹0.06 crore loss reported in the previous quarter. The stock surged 4.88% to ₹7.09 on February 1, 2026, though it remains 31.30% below its 52-week high of ₹10.32 amid persistent concerns about operational stability and financial sustainability.

Read full news article

When is the next results date for Hindustan Bio Sciences Ltd?

2026-01-20 23:16:12

The next results date for Hindustan Bio Sciences Ltd is scheduled for January 31, 2026....

Read full news article